Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CANX - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
VAMP3 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SLC39A6 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ASAH1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GHITM - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ADAM9 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
PGK1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ITGB1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SEPT2 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
TMEM245 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
APLP2 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
TMEM230 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SEC23A - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SELT - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
CALU - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
CD46 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
CD164 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
PON2 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on